Hepatocellular carcinoma: diagnosis, management, and prognosis

doi:10.1016/j.soc.2013.10.006

Review

. 2014 Apr;23(2):289-311.

doi: 10.1016/j.soc.2013.10.006. Epub 2013 Dec 7.

Hepatocellular carcinoma: diagnosis, management, and prognosis

Andrew J Page¹, David C Cosgrove², Benjamin Philosophe¹, Timothy M Pawlik³

Affiliations

¹ Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
² Department of Medical Oncology, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
³ Division of Surgical Oncology, Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Blalock 688, Baltimore, MD 21287, USA. Electronic address: tpawlik1@jhmi.edu.

PMID: 24560111
DOI: 10.1016/j.soc.2013.10.006

Review

Hepatocellular carcinoma: diagnosis, management, and prognosis

Andrew J Page et al. Surg Oncol Clin N Am. 2014 Apr.

. 2014 Apr;23(2):289-311.

doi: 10.1016/j.soc.2013.10.006. Epub 2013 Dec 7.

Authors

Andrew J Page¹, David C Cosgrove², Benjamin Philosophe¹, Timothy M Pawlik³

Affiliations

¹ Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
² Department of Medical Oncology, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
³ Division of Surgical Oncology, Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Blalock 688, Baltimore, MD 21287, USA. Electronic address: tpawlik1@jhmi.edu.

PMID: 24560111
DOI: 10.1016/j.soc.2013.10.006

Abstract

The successful management of hepatocellular carcinoma (HCC) requires a multidisciplinary approach, incorporating hepatologists, oncologists, surgical oncologists, transplant surgeons, and radiologists. With improvements in technology and better long-term outcomes data, management strategies for HCC have become more methodical and more successful. This article focuses on some of the most critical advances relating to carcinogenesis, surveillance, and management.

Keywords: Hepatocellular carcinoma; Locoregional therapy; Sorafenib; Transarterial chemoembolization (TACE); Transplantation.

PubMed Disclaimer

Cited by

Knockdown of CENPW Inhibits Hepatocellular Carcinoma Progression by Inactivating E2F Signaling.
Zhou Y, Chai H, Guo L, Dai Z, Lai J, Duan J, Liu Y, Ding Q. Zhou Y, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211007253. doi: 10.1177/15330338211007253. Technol Cancer Res Treat. 2021. PMID: 33973496 Free PMC article.
Comparison of Treatment Response and Survival Profiles Between Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients: A Prospective Cohort Study.
Wen P, Chen SD, Wang JR, Zeng YH. Wen P, et al. Oncol Res. 2019 May 7;27(5):583-592. doi: 10.3727/096504018X15368325811545. Oncol Res. 2019. PMID: 31053181 Free PMC article.
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients.
Shaker MK, Abdel Fattah HI, Sabbour GS, Montasser IF, Abdelhakam SM, El Hadidy E, Yousry R, El Dorry AK. Shaker MK, et al. World J Hepatol. 2017 Mar 28;9(9):469-476. doi: 10.4254/wjh.v9.i9.469. World J Hepatol. 2017. PMID: 28396717 Free PMC article.
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma.
Jiang Z, Jiang X, Chen S, Lai Y, Wei X, Li B, Lin S, Wang S, Wu Q, Liang Q, Liu Q, Peng M, Yu F, Weng J, Du X, Pei D, Liu P, Yao Y, Xue P, Li P. Jiang Z, et al. Front Immunol. 2017 Jan 11;7:690. doi: 10.3389/fimmu.2016.00690. eCollection 2016. Front Immunol. 2017. PMID: 28123387 Free PMC article.
A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma.
Xu L, Wang J, Kim Y, Shuang ZY, Zhang YJ, Lao XM, Li YQ, Chen MS, Pawlik TM, Xia JC, Li SP, Lau WY. Xu L, et al. Oncoimmunology. 2015 Oct 12;5(3):e1083671. doi: 10.1080/2162402X.2015.1083671. eCollection 2016 Mar. Oncoimmunology. 2015. PMID: 27141337 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Hepatocellular carcinoma: diagnosis, management, and prognosis

Affiliations

Hepatocellular carcinoma: diagnosis, management, and prognosis

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous